Ralph Aquila

1.4k total citations
15 papers, 446 citations indexed

About

Ralph Aquila is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Ralph Aquila has authored 15 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 4 papers in Clinical Psychology and 3 papers in Pharmacology. Recurrent topics in Ralph Aquila's work include Schizophrenia research and treatment (10 papers), Mental Health and Psychiatry (3 papers) and Mental Health and Patient Involvement (2 papers). Ralph Aquila is often cited by papers focused on Schizophrenia research and treatment (10 papers), Mental Health and Psychiatry (3 papers) and Mental Health and Patient Involvement (2 papers). Ralph Aquila collaborates with scholars based in United States and Ireland. Ralph Aquila's co-authors include Peter J. Weiden, Leslie Citrome, Allen W. Nyhuis, Haya Ascher‐Svanum, Bruce J. Kinon, Sandra L. Tunis, Douglas E. Faries, M.H. Emanuel, Annette Zygmunt and Arielle D. Stanford and has published in prestigious journals such as Value in Health, Community Mental Health Journal and CNS Spectrums.

In The Last Decade

Ralph Aquila

14 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Aquila United States 10 357 111 77 77 56 15 446
Jamie Karagianis Canada 13 379 1.1× 128 1.2× 51 0.7× 66 0.9× 93 1.7× 26 508
Rafael Gafoor United Kingdom 9 307 0.9× 148 1.3× 52 0.7× 139 1.8× 52 0.9× 22 472
Vivek H. Phutane India 12 367 1.0× 86 0.8× 129 1.7× 79 1.0× 31 0.6× 25 490
Eun Kee Chung South Korea 11 347 1.0× 107 1.0× 80 1.0× 88 1.1× 19 0.3× 15 454
Fuminari Misawa Japan 9 431 1.2× 93 0.8× 93 1.2× 90 1.2× 28 0.5× 28 488
Д. Набер Germany 10 250 0.7× 83 0.7× 41 0.5× 58 0.8× 38 0.7× 26 398
Mallik Greene United States 11 455 1.3× 92 0.8× 70 0.9× 64 0.8× 14 0.3× 49 563
Margaret Harris United Kingdom 12 174 0.5× 105 0.9× 35 0.5× 58 0.8× 30 0.5× 19 381
B. Lachaux France 9 476 1.3× 182 1.6× 58 0.8× 227 2.9× 19 0.3× 30 601
Hans Rittmannsberger Austria 13 341 1.0× 158 1.4× 58 0.8× 61 0.8× 15 0.3× 57 591

Countries citing papers authored by Ralph Aquila

Since Specialization
Citations

This map shows the geographic impact of Ralph Aquila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Aquila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Aquila more than expected).

Fields of papers citing papers by Ralph Aquila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Aquila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Aquila. The network helps show where Ralph Aquila may publish in the future.

Co-authorship network of co-authors of Ralph Aquila

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Aquila. A scholar is included among the top collaborators of Ralph Aquila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Aquila. Ralph Aquila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Nasrallah, Henry A., et al.. (2025). Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil. Psychopharmacology Bulletin. 47(3). 35–43.
2.
Aquila, Ralph, et al.. (2021). Clubhouses as Essential Communities During the COVID-19 Pandemic. Journal of Psychosocial Rehabilitation and Mental Health. 9(2). 149–157. 4 indexed citations
3.
Nasrallah, Henry A., Ralph Aquila, Yangchun Du, et al.. (2018). Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia. CNS Spectrums. 24(4). 395–403. 21 indexed citations
4.
Aquila, Ralph & Leslie Citrome. (2015). Cognitive impairment in schizophrenia: the great unmet need. CNS Spectrums. 20(S1). 32–40. 23 indexed citations
5.
Aquila, Ralph, et al.. (2006). The store front, Fountain House, and the rehabilitation alliance.. PubMed. 8(3). 67–67. 6 indexed citations
6.
Tunis, Sandra L., Douglas E. Faries, Allen W. Nyhuis, et al.. (2005). Cost-Effectiveness of Olanzapine as First-Line Treatment for Schizophrenia: Results from a Randomized, Open-Label, 1-Year Trial. Value in Health. 9(2). 77–89. 48 indexed citations
7.
Shafer, Robert W., Laura Smeaton, Gregory K. Robbins, et al.. (2003). AIDS CLINICAL TRIALS GROUP 384 TEAM. COMPARISON OF FOUR-DRUG REGIMENS AND PAIRS OF SEQUENTIAL THREE-DRUG REGIMENS AS INITIAL THERAPY FOR HIV-1 INFECTION. 349(24). 2304–2315. 9 indexed citations
8.
Aquila, Ralph. (2002). Management of weight gain in patients with schizophrenia.. PubMed. 63 Suppl 4. 33–6. 32 indexed citations
9.
Aquila, Ralph, et al.. (2000). Interventions for Weight Gain in Adults Treated With Novel Antipsychotics. The Primary Care Companion For CNS Disorders. 2(1). 20–23. 50 indexed citations
10.
Grunebaum, Michael F., Ralph Aquila, Laura Portera, Andrew C. Leon, & Peter J. Weiden. (1999). Predictors of Management Problems in Supported Housing: A Pilot Study. Community Mental Health Journal. 35(2). 127–133. 7 indexed citations
11.
Aquila, Ralph, Peter J. Weiden, & M.H. Emanuel. (1999). Compliance and the rehabilitation alliance.. PubMed. 60 Suppl 19. 23–7; discussion 28. 22 indexed citations
12.
Aquila, Ralph, et al.. (1999). The rehabilitation alliance in practice: The clubhouse connection.. Psychiatric Rehabilitation Journal. 23(1). 19–23. 14 indexed citations
13.
Weiden, Peter J., et al.. (1998). Long-term considerations after switching antipsychotics.. PubMed. 59 Suppl 19. 36–49. 22 indexed citations
14.
Weiden, Peter J., et al.. (1997). Switching antipsychotic medications.. PubMed. 58 Suppl 10. 63–72. 72 indexed citations
15.
Weiden, Peter J., et al.. (1996). Atypical antipsychotic drugs and long-term outcome in schizophrenia.. PubMed. 57 Suppl 11. 53–60. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie Karagianis Breakdown of academic impact, for papers by Rafael Gafoor Breakdown of academic impact, for papers by Vivek H. Phutane Breakdown of academic impact, for papers by Eun Kee Chung Breakdown of academic impact, for papers by Fuminari Misawa Breakdown of academic impact, for papers by Д. Набер Breakdown of academic impact, for papers by Mallik Greene Breakdown of academic impact, for papers by Margaret Harris Breakdown of academic impact, for papers by B. Lachaux Breakdown of academic impact, for papers by Hans Rittmannsberger
Rankless by CCL
2026